We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Mortality Among Patients Prescribed Buprenorphine for Opioid Use Disorder After Disenrollment from an Insurance Plan and Healthcare System.
- Authors
Nguyen, Anh P.; Glanz, Jason M.; Shoup, Jo Ann; Campbell, Cynthia I.; Clarke, Christina L.; Ford, Morgan A.; Binswanger, Ingrid A.
- Abstract
While we do not know whether individuals disenrolled due to insurance loss or changes in insurance, results suggest that treatment discontinuation is high-risk and that insurance disenrollment may impede buprenorphine treatment retention[3] by inducing high-risk gaps or transitions in care. Keywords: insurance instability; opioid use disorder; mortality EN insurance instability opioid use disorder mortality 2882 2884 3 08/29/22 20220805 NES 220805 INTRODUCTION Medications are highly effective in treating opioid use disorder (OUD) but generally require long-term use to prevent relapse and fatalities.[1],[2] Health insurance disenrollment poses a significant challenge to sustaining treatment and can lead to high-risk treatment discontinuation and transitions in care.[2]-[5] In this study, we examined disenrollment from membership in an integrated insurance plan and health care delivery system (Kaiser Permanente Colorado) and its association with all-cause mortality among patients prescribed buprenorphine for OUD.
- Subjects
OPIOID abuse; BUPRENORPHINE; MORTALITY; ALCOHOLISM; MEDICAL care
- Publication
JGIM: Journal of General Internal Medicine, 2022, Vol 37, Issue 11, p2882
- ISSN
0884-8734
- Publication type
Article
- DOI
10.1007/s11606-021-07344-w